Disrupting Japan

Right now, it looks like the most profitable business models that are emerging from the mapping of the human genome are not in the field of medicine, but in a variety of B2C business models focused on consumer marketing. That may be a surprising claim, but if the past 40 years of life sciences have taught us anything, it's that our genetic information will be both more valuable and harder to understand than we expect it to be. Today, I’d like you to meet Tomohiro Takano, CEO and founder of Awakens.  Awakens is opening up the genome to make it more accessible and understandable to you and me. They are designing a genetic marketplace that will serve both B2B and B2C clients, and they are working with other startups to develop applications that will leave some readers impressed and excited, and others appalled and concerned. So it’s probably best to let Tomo tell you about it. Show Notes Why people will share their DNA information How to choose your customers as a genetics startup Why developing B2B